MONALEESA2_1: MONALEESA2, figure 1
In raredd/kmdata: A Database of Reconstructed Individual Patient Level Data from Oncology Clinical Trials
MONALEESA2_1 R Documentation
MONALEESA2, figure 1
Description
Kaplan-Meier digitized data from MONALEESA2, figure 1 (PMID 27717303). A reported sample size of 668 for a primary endpoint of PFS in breast cancer.
Usage
MONALEESA2_1
Format
A data frame of 668 observations and 3 variables:
time event time (in months)
event PFS event indicator (0: no event, 1: event)
arm treatment arms (placebo, ribociclib_letrozole)
Source
Hortobagyi GN, Stemmer SM, Burris HA, et al. Ribociclib as First-Line
Therapy for HR-Positive, Advanced Breast Cancer. N Engl J Med 2016;
375: 1738–48.
Examples
summary(MONALEESA2_1)
kmplot(MONALEESA2_1)
raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
| MONALEESA2_1 | R Documentation |
MONALEESA2, figure 1
Description
Kaplan-Meier digitized data from MONALEESA2, figure 1 (PMID 27717303). A reported sample size of 668 for a primary endpoint of PFS in breast cancer.
Usage
MONALEESA2_1
Format
A data frame of 668 observations and 3 variables:
time | event time (in months) | |
event | PFS event indicator (0: no event, 1: event) |
|
arm | treatment arms (placebo, ribociclib_letrozole) | |
Source
Hortobagyi GN, Stemmer SM, Burris HA, et al. Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer. N Engl J Med 2016; 375: 1738–48.
Examples
summary(MONALEESA2_1)
kmplot(MONALEESA2_1)
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
Embedding an R snippet on your website
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.